exv10w9






Exhibit 10.9



CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A
REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION.




OMEPRAZOLE SUPPLY AGREEMENT




AMENDMENT NO. 4



     This Amendment (the “Amendment”) by and among Santarus, Inc., a Delaware corporation
having a principal place of business at 3721 Valley Centre Drive, Suite 400, San Diego, CA 92130
(“SANTARUS”), Interchem Trading Corporation d/b/a Interchem Corporation, a New Jersey corporation
located at 120 Route 17 North, Paramus, New Jersey 07652 (“INTERCHEM”), and Union Quimico
Farmaceutica, S.A., a corporation of Spain located at Mallorca, 262, 08008, Barcelona, Spain
(“UQUIFA”) is entered into as of October 30, 2009 (the “Effective Date”).



     Whereas, SANTARUS, INTERCHEM and UQUIFA have entered into that certain Omeprazole
Supply Agreement, dated September 25, 2003, as amended (the “Agreement”), wherein UQUIFA agrees to
manufacture and supply Omeprazole to SANTARUS;



     Whereas, Section 5.3 of the Agreement provides that the price for the Omeprazole to
be purchased by SANTARUS under the Agreement shall be renegotiated by SANTARUS, on the one hand,
and INTERCHEM and UQUIFA, on the other hand, in good faith on [* * *] at a
mutually agreed upon time and reasonably in advance of the expiration of the applicable [*
* *] period and taking into account then prevailing market conditions; and



     Whereas, SANTARUS, INTERCHEM and UQUIFA desire to amend and restate Schedule C of the
Agreement pursuant to and in accordance with Section 5.3 in order to set a new price for the
Omeprazole to be purchased by SANTARUS under the Agreement and to clarify the timing for future
price adjustments.



     Now, Therefore, in consideration of the foregoing recitals and the mutual agreements
contained in this Amendment, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, SANTARUS, INTERCHEM and UQUIFA, intending to be
legally bound hereby, agree as follows:



     1. Schedule C of the Agreement is hereby amended and restated in its entirety to read as
follows:



“SCHEDULE C




PRICING AND SHIPPING TERMS


Freight Terms: INTERCHEM and UQUIFA shall make all necessary shipping arrangements to SANTARUS’
designated facility, [* * *] SANTARUS’ designated facility, freight
prepaid.



Shipping Method: Air Freight



Price: [* * *]




[* * *]

[* * *]






 




			
	***	 	Certain information on this page has been omitted
and filed separately with the Securities and Exchange Commission. Confidential
treatment has been requested with respect to the omitted portions.














 










     2. Except as specifically set forth herein, all of the terms and provisions of the Agreement
shall remain unchanged, unmodified and in full force and effect, and the Agreement shall be read
together and construed with this Amendment.



     3. Capitalized terms used but not otherwise defined herein shall have the meanings assigned to
such terms in the Agreement.



     4. This Amendment may be executed in any number of counterparts, all of which taken together
shall constitute one and the same instrument and any of the parties hereto may execute this
Amendment by signing any such counterpart.



     In Witness Whereof, the parties hereto have caused this Amendment to be executed as
of the date first above written.



	 	 	 	 	 	 	 
	Santarus, Inc.,
a Delaware corporation	 	Interchem Trading Corporation


d/b/a Interchem Corporation,

a New Jersey corporation
	 
	 	 	 	 	 	 
	By:

	 	/s/ Warren Hall	 	 	 	 
	 

	 	 	 	 	 	 
	Name:

	 	Warren Hall
	 	By:
	 	/s/ Joseph Pizza
	 

	 	 	 	 	 	 
	Title:

	 	Senior Vice President, Product
	 	Name:
	 	Joseph Pizza
	 

	 	Development and Manufacturing
	 	Title:
	 	President
	 
	 	 	 	 	 	 
	Union Quimico Farmaceutica, S.A.,
a corporation of Spain	 	 	 	 
	 
	 	 	 	 	 	 
	By:

	 	/s/ Mark Robbins	 	 	 	 
	 

	 	 	 	 	 	 
	Name:

	 	Mark Robbins	 	 	 	 
	Title:

	 	Chief Executive